Cyclin D1 differential activation and its prognostic impact in patients with advanced breast cancer treated with trastuzumab.
Title | Cyclin D1 differential activation and its prognostic impact in patients with advanced breast cancer treated with trastuzumab. |
Publication Type | Journal Article |
Year of Publication | 2019 |
Authors | Mountzios, G., Kotoula V., Kolliou G-A., Papadopoulou K., Lazaridis G., Christodoulou C., Pentheroudakis G., Skondra M., Koutras A., Linardou H., Razis E., Papakostas P., Chrisafi S., Aravantinos G., Nicolaou I., Goussia A., Kalogeras K., Pectasides D., & Fountzilas G. |
Journal | ESMO Open |
Volume | 4 |
Issue | 2 |
Pagination | e000441 |
Date Published | 2019 |
ISSN | 2059-7029 |
Abstract | Introduction: We sought to determine the level of activation of the critical components of the cyclin D1-mediated pathway and to evaluate their prognostic significance across the different molecular subtypes of advanced breast cancer. |
DOI | 10.1136/esmoopen-2018-000441 |
Alternate Journal | ESMO Open |
PubMed ID | 31231556 |
PubMed Central ID | PMC6555606 |